129 related articles for article (PubMed ID: 9802328)
1. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes.
Sasvári-Székely M; Spasokoukotskaja T; Szóke M; Csapó Z; Turi A; Szántó I; Eriksson S; Staub M
Biochem Pharmacol; 1998 Nov; 56(9):1175-9. PubMed ID: 9802328
[TBL] [Abstract][Full Text] [Related]
2. Activation of deoxycytidine kinase during inhibition of DNA synthesis in human lymphocytes.
Sasvári-Székely M; Csapó Z; Spasokoukotskaja T; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():519-23. PubMed ID: 9598121
[TBL] [Abstract][Full Text] [Related]
3. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
5. A novel effect of the new antileukemic drug, 2-chloro-2'-deoxyadenosine, in human lymphocytes.
Sasvári-Székely M; Piróth Z; Kazimierczuk Z; Staub M
Biochem Biophys Res Commun; 1994 Sep; 203(3):1378-84. PubMed ID: 7945284
[TBL] [Abstract][Full Text] [Related]
6. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
[TBL] [Abstract][Full Text] [Related]
9. Human tonsillar lymphocytes as targets for immunosuppressive and anticancer drugs.
Staub M; Sasvari-Szekely M; Spasokukotskaja T; Piroth Z; Kazimierczuk Z
Acta Otolaryngol Suppl; 1996; 523():124-7. PubMed ID: 9082756
[TBL] [Abstract][Full Text] [Related]
10. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
11. Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Talianidis I; Eriksson S; Staub M
Biochem Pharmacol; 2001 Jan; 61(2):191-7. PubMed ID: 11163333
[TBL] [Abstract][Full Text] [Related]
12. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
13. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
14. Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes.
Csapo Z; Keszler G; Safrany G; Spasokoukotskaja T; Talianidis I; Staub M; Sasvari-Szekely M
Biochem Pharmacol; 2003 Jun; 65(12):2031-9. PubMed ID: 12787883
[TBL] [Abstract][Full Text] [Related]
15. Similar changes were induced by Cladribine and by gemcitabine, in the deoxypyrimidine salvage, during short-term treatments.
Csapó Z; Keszler G; Sasvári-Székely M; Smid K; Noordhuis P; Peters GJ; Staub M
Adv Exp Med Biol; 1998; 431():525-9. PubMed ID: 9598122
[TBL] [Abstract][Full Text] [Related]
16. Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis.
Keszler G; Spasokoukotskaja T; Csapo Z; Virga S; Staub M; Sasvari-Szekely M
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1335-42. PubMed ID: 15571254
[TBL] [Abstract][Full Text] [Related]
17. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
18. Deoxycytidine kinase can be also potentiated by the G-protein activator NaF in cells.
Staub M; Csapó Z; Spasokukotskaja T; Sasvári-Székely M
Adv Exp Med Biol; 1998; 431():425-8. PubMed ID: 9598103
[TBL] [Abstract][Full Text] [Related]
19. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
Leegwater PA; De Abreu RA; Albertioni F
Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
[TBL] [Abstract][Full Text] [Related]
20. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
